Company intelligence / Profile preview

Genetic PCR Solutions

Ownership: Private
Development stage: Commercial

Overview

Genetic PCR Solutions offers commercial real-time PCR and qPCR diagnostic kits for rapid and sensitive detection of a wide range of microbial pathogens. The company has launched products such as a Monkeypox virus qPCR kit and provides custom-designed assays to meet specific client needs. No clinical trial results are reported; products are used in laboratory diagnostics.

Therapeutic areas: Infectious Diseases
Modalities: Device (PCR detection kits)Diagnostic kit (Real-time PCR/qPCR-based diagnostics)Molecular diagnostic assay
Industry: Molecular Diagnostics

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on Genetic PCR Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genetic PCR Solutions.

Explore the full profile